4Tan -Chiu E, Wang JP, Costantino JP, et al. Effect of tamoxifen on benign breast disease in women at high risk for breast cancer [ J ]. J Natl Cancer Inst, 2003,95 (4) : 302-307.
5Tan CE, Wang JP, Costantino JP, et al. Effects of tamoxifen on benign breast disease in women at high risk for breast cancer[J] .J Natl Cancer Inst, 2003,95 (4) : 302-307.
6Cuzlck J, Warwick J, Pinney E, et al. Tamoxifen and breast density in women at increased risk of breast cancer[J] .J Natl Cancer Inst,2004,96(8) :621-628.
7Gumm R, Cunnick GH, Mokbel K. Evidence for the management of mastalgia[ J ]. Curr Med Res Opin, 2004,20 ( 5 ) : 681-684.
8Winkler UH, Schindler AE, Brinkmann US, et al. Cyclic progestin therapy for the management of mastopathy and mastodynia[ J]. Gynecol Endocrinol, 2001, [ Suool 6 ] : 37-43.
9Fallois JV, Etterli-Billenkamp U, Schindler EM, et al. Danazol for treatment of fibrocystic mastopathy [ J ]. Zentralbl Gynakol, 1995, 117(9) :457-465.
10Colin C.Treatment of cystic mastopathy with puncture and administration of an LHRH analogue [ J ] . Contracept Fertil Sex, 1994,22 ( 3 ) :183-186.
